Publikationen von Matthias Lienhard
Alle Typen
Zeitschriftenartikel (27)
1.
Zeitschriftenartikel
2022 (2022)
Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies. Blood 2.
Zeitschriftenartikel
4 (1), lqab128 (2022)
Matching anticancer compounds and tumor cell lines by neural networks with ranking loss. NAR: genomics and bioinformatics 3.
Zeitschriftenartikel
22 (17), 9337 (2021)
Altered DNA Methylation Profiles in SF3B1 Mutated CLL Patients. International Journal of Molecular Sciences 4.
Zeitschriftenartikel
19, 19:274 (2021)
Large-scale literature mining to assess the relation between anti-cancer drugs and cancer types. Journal of Translational Medicine 5.
Zeitschriftenartikel
12, 3307 (2021)
Crowdsourced mapping of unexplored target space of kinase inhibitors. Nature Communications 6.
Zeitschriftenartikel
81 (1), S. 38 - 49 (2021)
PWD/Ph-encoded genetic variants modulate the cellular Wnt/β-Catenin response to suppress ApcMin-triggered intestinal tumor formation. Cancer research: an official organ of the American Association for Cancer Research 7.
Zeitschriftenartikel
3, 573 (2020)
Network integration and modelling of dynamic drug responses at multi-omics levels. Communications Biology 8.
Zeitschriftenartikel
9 (9), 4641 (2019)
DMSO induces drastic changes in human cellular processes and epigenetic landscape in vitro. Scientific Reports 9.
Zeitschriftenartikel
21 (2), S. 198 - 213 (2019)
Combined Targeted Re-Sequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for PARP1 Inhibitor Sensitivity Testing. The Journal of Molecular Diagnostics 10.
Zeitschriftenartikel
21 (2), S. 198 - 213 (2019)
Combined Targeted Resequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for Poly(ADP-Ribose) Polymerase 1 Inhibitor Sensitivity Testing. The Journal of Molecular Diagnostics 11.
Zeitschriftenartikel
2018, 295:S215 (2018)
DMSO-induced drastic changes in cellular processes and epigenetic landscape in vitro. TOXICOLOGY LETTERS 12.
Zeitschriftenartikel
10 (1), 10:55 (2018)
Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance. Genome Medicine 13.
Zeitschriftenartikel
11 (10), S. 1889 - 1907 (2016)
Analyzing and interpreting genome data at the network level with ConsensusPathDB. Nature Protocols 14.
Zeitschriftenartikel
48 (6), S. 593 - 599 (2016)
Punctuated bursts in human male demography inferred from 1,244 worldwide Y-chromosome sequences. Nature Genetics 15.
Zeitschriftenartikel
526 (7571), S. 68 - 74 (2015)
A global reference for human genetic variation. Nature 16.
Zeitschriftenartikel
112 (31), S. E4236 - E4245 (2015)
Simultaneous deletion of the methylcytosine oxidases Tet1 and Tet3 increases transcriptome variability in early embryogenesis. Proceedings of the National Academy of Sciences of the United States of America 17.
Zeitschriftenartikel
17 (5), S. 545 - 557 (2015)
The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine. Nature Cell Biology 18.
Zeitschriftenartikel
42 (14), e110 (2014)
ARH-seq: identification of differential splicing in RNA-seq data. Nucleic Acids Research (London) 19.
Zeitschriftenartikel
15 (8), S. 777 - 788 (2014)
Epigenomic analysis of primary human T cells reveals enhancers associated with TH2 memory cell differentiation and asthma susceptibility. Nature Immunology 20.
Zeitschriftenartikel
5, 5:3934 (2014)
Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel. Nature Communications